|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1993-5-24
|
|
pubmed:abstractText |
This study determines the survival benefit and cost-effectiveness of adjuvant chemotherapy in elderly women with breast cancer. In addition, the analysis measures the impact of substituting active life expectancy for survival in the clinical decision.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
777-82
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:8478671-Age Factors,
pubmed-meshheading:8478671-Aged,
pubmed-meshheading:8478671-Aged, 80 and over,
pubmed-meshheading:8478671-Antineoplastic Agents,
pubmed-meshheading:8478671-Breast Neoplasms,
pubmed-meshheading:8478671-Chemotherapy, Adjuvant,
pubmed-meshheading:8478671-Cost-Benefit Analysis,
pubmed-meshheading:8478671-Decision Support Techniques,
pubmed-meshheading:8478671-Female,
pubmed-meshheading:8478671-Humans,
pubmed-meshheading:8478671-Lymphatic Metastasis,
pubmed-meshheading:8478671-Middle Aged,
pubmed-meshheading:8478671-Quality of Life,
pubmed-meshheading:8478671-Survival Rate,
pubmed-meshheading:8478671-Treatment Outcome
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life-expectancy outcomes.
|
|
pubmed:affiliation |
Department of Internal Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0037.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
